Nephros, Inc. (NEPH)
4.55
+0.24
(+5.57%)
USD |
NASDAQ |
Aug 28, 16:00
4.55
0.00 (0.00%)
After-Hours: 20:00
Nephros Research and Development Expense (TTM) : 1.445M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.445M |
| March 31, 2026 | 1.39M |
| December 31, 2025 | 1.339M |
| September 30, 2025 | 1.196M |
| June 30, 2025 | 1.046M |
| March 31, 2025 | 0.989M |
| December 31, 2024 | 0.906M |
| September 30, 2024 | 0.862M |
| June 30, 2024 | 0.879M |
| March 31, 2024 | 0.846M |
| December 31, 2023 | 0.873M |
| September 30, 2023 | 1.024M |
| June 30, 2023 | 1.071M |
| March 31, 2023 | 1.123M |
| December 31, 2022 | 1.256M |
| September 30, 2022 | 1.225M |
| June 30, 2022 | 1.368M |
| March 31, 2022 | 1.582M |
| December 31, 2021 | 1.766M |
| September 30, 2021 | 2.047M |
| June 30, 2021 | 2.403M |
| March 31, 2021 | 2.752M |
| December 31, 2020 | 2.759M |
| September 30, 2020 | 2.914M |
| June 30, 2020 | 2.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.897M |
| December 31, 2019 | 3.09M |
| September 30, 2019 | 2.872M |
| June 30, 2019 | 2.447M |
| March 31, 2019 | 2.006M |
| December 31, 2018 | 1.539M |
| September 30, 2018 | 1.251M |
| June 30, 2018 | 1.136M |
| March 31, 2018 | 1.061M |
| December 31, 2017 | 1.003M |
| September 30, 2017 | 1.061M |
| June 30, 2017 | 1.065M |
| March 31, 2017 | 1.042M |
| December 31, 2016 | 1.08M |
| September 30, 2016 | 1.008M |
| June 30, 2016 | 0.993M |
| March 31, 2016 | 0.903M |
| December 31, 2015 | 0.826M |
| September 30, 2015 | 0.842M |
| June 30, 2015 | 0.794M |
| March 31, 2015 | 0.81M |
| December 31, 2014 | 0.781M |
| September 30, 2014 | 0.66M |
| June 30, 2014 | 0.686M |
| March 31, 2014 | 0.765M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median